+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Medical Imaging Industry Quarterly Tracker, Q1 2019

  • ID: 4846372
  • Report
  • Region: Global
  • 55 Pages
  • Frost & Sullivan
1 of 3
Quarterly Edition of Trends in Medical Imaging and Informatics Covering Competition, Policy, Regulatory, and Clinical Areas

FEATURED COMPANIES

  • ACC
  • ACR
  • CE
  • ESR
  • FDA
  • RSNA
  • MORE

The medical imaging and informatics industry is evolving rapidly, and new products and solutions are launched every other day. As the reimbursement environment is transitioning from fee-for-service to value-based payment, vendors' business models and value propositions are undergoing drastic changes. New evidence regarding the use of certain techniques in imaging is influencing changes in the standard of care. On a macro level, the government's policies on reimbursement and regulations tend to impact the performance of industry participants, if their internal teams delay the calibration of the strategic actions needed to thrive in this new environment.

To help its clients address challenges in an intensely competitive environment, the publisher has introduced the Medical Imaging and Informatics Quarterly Insights tracker that will monitor market factors and significant events and qualitatively assess their impact on the industry; this will cover the diagnostic imaging, image-guided therapies, and imaging informatics segments.

Research Scope

The scope of this deliverable covers the following segments:

Clinical Trends

  • Disruptive trends that impact the current ‘gold standard'
  • Trends that indicate the clinical adoption of new solutions/products
  • Important announcements from associations such as RSNA, ESR, ACR, and ACC

Competition

  • New product launches and capabilities
  • Mergers and acquisitions
  • FDA and CE approvals
  • Major FDA and CE recalls/warnings

Policies and Regulations

  • Region-specific introduction of new regulatory approvals
  • Reimbursement achievements or setbacks

Event Highlights

  • Major event highlights in the quarter that cover important themes - this is derived by studying the messaging and communications, product launches, and product promotions at the events
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • ACC
  • ACR
  • CE
  • ESR
  • FDA
  • RSNA
  • MORE

1. Executive Summary

  • Methodology
  • Scope
  • Key Takeaways

2. Competition

  • Competition - Long-term Business Contracts
  • Competition - New Launches
  • Competition - Corporate Highlights
  • Competition - Business Collaboration
  • FDA Approvals from Top-tier Companies (January-March 2019)
  • FDA Approvals from Other Companies (January-March 2019)
  • Notable CE Approvals
  • FDA Recalls

3. Policies and Regulations

4. Clinical Trends

5. Event Highlights

6. Conclusion

  • Legal Disclaimer

7. Appendix

  • List of Exhibits
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • ACC
  • ACR
  • CE
  • ESR
  • FDA
  • RSNA
Note: Product cover images may vary from those shown
Adroll
adroll